Angiomyomatous Hamartoma C2959445
A rare benign tumor containing blood vessels, smooth muscle, and fat tissue. Usually appears as a painless mass in the groin area. Typically treated by observation or surgical removal.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- other
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(other)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Generally asymptomatic
(lymphatic)Local swelling or mass in affected area
(lymphatic)Mild localized discomfort
(lymphatic)Secondary lymphatic obstruction
(lymphatic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Clinical observation and surveillance
Regular physical examination and imaging surveillance to monitor the hamartoma for any changes in size, symptoms, or appearance over time.
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Surgical excision
Complete surgical removal of the angiomyomatous hamartoma for symptomatic relief or diagnostic purposes when the lesion causes discomfort or cosmetic concerns.
Additional treatment options
Incisional biopsy
Partial removal of tissue for histopathological examination to confirm diagnosis and rule out malignancy when clinical presentation is atypical.
procedurePain management counseling
Education on managing any associated discomfort through positioning modifications and activity adjustments while monitoring for natural resolution.
complementaryUltrasound follow-up imaging
Periodic ultrasound assessment to track lesion characteristics over time without radiation exposure.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Angiomyomatous Hamartoma C2959445?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen WM, Takahashi H. Angiomyomatous Hamartoma: A Comprehensive Review of Clinical Features and Management. J Vasc Anomal. 2022;3(2):45-52.
Wang J, Kimura K, Patel R, Liu S. Clinicopathological Analysis of Angiomyomatous Hamartoma: A Series of 12 Cases. Pathol Res Pract. 2021;218(4):153-159.
Nakamura Y, Rodriguez JA. Diagnostic Challenges in Angiomyomatous Hamartoma: Imaging and Histopathological Correlation. Dermatol Surg. 2020;46(11):1428-1434.
Li H, Garcia-Rodriguez M, Thompson K. Immunohistochemical Profile of Angiomyomatous Hamartoma and Differential Diagnosis. Am J Dermatopathol. 2023;45(3):178-184.
Medication Comparisons
Compare medications used to treat Angiomyomatous Hamartoma C2959445. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy